# Pharmacokinetic Interaction Study of Steady-state Tipranavir/Ritonavir (TPV/r) With Single-dose Valaciclovir (VAL) in Healthy Volunteers

> **NCT02226978** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 29 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Tipranavir
- **DRUG:** Ritonavir
- **DRUG:** Valaciclovir

## Key facts

- **NCT ID:** NCT02226978
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2007-05
- **Final completion:** —
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2014-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02226978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02226978, "Pharmacokinetic Interaction Study of Steady-state Tipranavir/Ritonavir (TPV/r) With Single-dose Valaciclovir (VAL) in Healthy Volunteers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02226978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*